CRM Stock Slips In Early Trade - This Analyst Says Salesforce Results, Outlook Unlikely To Win Over Either Bulls Or Bears
Salesforce (CRM) shares fell more than 2.5% after Q1 results and guidance did not satisfy analysts. DA Davidson cut its price target to $175 (Neutral) and BMO Capital to $215 (Outperform). Roth Capital kept Buy and $325. Q1 revenue was $11.13B and adjusted EPS $3.88; Q2 revenue guided to $11.03B and FY27 revenue to $45.9B-$46.2B.
How this was made
The 30-second read
Why it matters
Traders should focus on the gap between reported beats (revenue and adjusted EPS) and forward signals (Q2 revenue miss and FY27 revenue range), plus the immediate sell-side PT cuts that can affect positioning and near-term flows.
Market read
Analyst PT cuts and a guidance miss narrative are likely to keep CRM trading sensitive to any follow-through on revenue acceleration expectations.
What to watch
The article notes a $25B debt-funded accelerated buyback supporting EPS growth, which can cushion valuation even when top-line growth is questioned.
Background
The piece frames Salesforce’s Q1 print and FY27 outlook as not providing enough “ammunition” for bulls, while bears see limited change to growth expectations.
Ticker impact
Salesforce shares slipped after Q1 results and guidance were seen as insufficient, prompting multiple analysts to cut price targets and keep ratings mixed.
Choppy, range-bound trading likely until FY27 H2 revenue acceleration evidence emerges.
The article cites Q2 revenue guidance below consensus and FY27 revenue range that misses the Street midpoint, plus PT reductions from DA Davidson and BMO, which typically weigh on the stock near term.
Market effects
Reinforces a cautious read-through for enterprise software names where investors demand clear, sustained revenue acceleration.
No specific regional catalyst beyond US software sentiment.
Limited, as the story is company-specific analyst reaction to Salesforce guidance.
Counterpoint
The stock reaction may over-discount the Informatica acquisition contribution and cost discipline, with upside dependent on whether FY27 H2 acceleration materializes.
Key entities
- companySalesforce
Subject of the article, with Q1 results, Q2 guidance, and FY27 revenue range driving analyst reactions.
- analyst_firmDA Davidson
Lowered CRM price target to $175 from $200 and kept Neutral, citing insufficient support for the FY27 H2 acceleration narrative.
- analyst_firmBMO Capital
Cut CRM price target to $215 from $225 and kept Outperform, arguing guidance is not enough to sway bulls or bears.
- analyst_firmRoth Capital
Maintained Buy rating and $325 price target, pointing to cost cuts and the accelerated buyback supporting EPS.
